Phase II clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer

Phase II clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer - 2015


MedStar Health Research Institute
MedStar Washington Hospital Center
MedStar Washington Hospital Center


Medicine/Endocrinology
Medicine/Nuclear Medicine

Powered by Koha